1d:I[2890,["266","static/chunks/870fdd6f-4fcc92c129a57d11.js","970","static/chunks/970-91a3a37cc668faba.js","857","static/chunks/857-3b2a1421afa266d2.js","965","static/chunks/app/podcasts/episode/%5BpodcastEpisodeGuid%5D/page-e939c6b91b4a25d4.js"],"default"] 1e:I[1318,["266","static/chunks/870fdd6f-4fcc92c129a57d11.js","970","static/chunks/970-91a3a37cc668faba.js","857","static/chunks/857-3b2a1421afa266d2.js","965","static/chunks/app/podcasts/episode/%5BpodcastEpisodeGuid%5D/page-e939c6b91b4a25d4.js"],"default"] 1f:T48e,

As certain psychedelic drugs receive "breakthrough" status from the FDA for the treatment of serious mental-health conditions, the wellness industry is looking to commodify the science—with a polarizing response from the medical community. Maya Singer, turns on, tunes in, and drops some knowledge.

Find the full story here. For more from Maya Singer and VOGUE, make sure to subscribe to VOGUE Stories on:

Apple Podcasts: podcasts.apple.com/us/podcast/vogue-stories
Spotify: open.spotify.com/vogue-stories
Google: podcasts.google.com/vogue-stories

or wherever you listen to podcasts.

Learn about your ad choices: dovetail.prx.org/ad-choices

‌

Episode description

Trip Adviser: Psychedelic Wellness Has Arrived

Episode description